Deutsch M. Ductal carcinoma in situ recurrent on the chest wall after mastectomy. Clin Oncol ( R Coll Radiol ). 1999;11:61–2.Deutsch M: Ductal carcinoma in situ recurrent on the chest wall after mastectomy. Clin Oncol (R Coll Radiol) 11:61-62, 1999...
Five-year survival rates range from approximately 60% in patients with carcinoma in situ to less than 4% in patients with distant metastases. Because survival correlates closely to extent of disease, precise clinical staging is a critical component of determining appropriate treatment options. ...
M. Deutsch, "Ductal carcinoma in situ recurrent on the chest wall after mastectomy," Clinical Oncology, vol. 11, no. 1, pp. 61-62, 1999.Deutsch M: Ductal carcinoma in situ recurrent on the chest wall after mastectomy. Clin Oncol (R Coll Radiol) 11:61-62, 1999...
Deutsch M, Rosenstein MM. Ductal carcinoma in situ (DCIS) of the male breast treated by lumpectomy and brest irradiation. Clin Oncol (R Coll Radiol). 1998;10:204-5.Deutsch M, Rosenstein MM. Ductal carcinoma in situ (DCIS) of the male breast treated by lumpectomy and breast irradiation....
Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ - ScienceDirectdoi:10.1016/S0140-6736(03)14474-1C Zammit and A Yelland and G DeutschThe Lancet
A retrospective study demonstrated that 70% of cutaneous squamous cell carcinoma in situ (cSCC-IS) cases in immunocompetent patients cleared after biopsy but only 47% of cases were cleared in immunocompromised patients. This suggests that treatment of premalignant lesions in immunosuppressed patients ...